Dobutamine
- Product NDC
- 14335-172
- 11-digit product format
- 143350172
- Labeler code
- 14335
- Product ID
- 14335-172_f153e636-62ab-3b86-e053-2995a90a36c1
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Dobutamine
- Dosage form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Labeler
- Hainan Poly Pharm. Co., Ltd.
- Application
- ANDA216131
- Marketing category
- ANDA
- Marketing start
- 2021-06-01
- Marketing end
- 0000-00-00
- Substance
- DOBUTAMINE HYDROCHLORIDE
- Active strength
- 13 mg/mL
- Pharmacologic classes
- Adrenergic beta-Agonists [MoA], beta-Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2024-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 14335-172-01 | Dobutamine | 40 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION, CONCENTRATE | 40 | | 2 |
| 14335-172-01 | Dobutamine | 1 in 1 CARTON | INJECTION, SOLUTION, CONCENTRATE | 1 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 14335-172 | DOBUTAMINE INJECTION, SOLUTION, CONCENTRATE [HAINAN POLY PHARM. CO., LTD.] | 2 | Legacy NDC, 2 package rows | 20230104_9794e9d0-c8b7-4d18-8cd1-15cc4f2a9a55.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 14335-172-01 | 14335017201 | 1 VIAL, SINGLE-DOSE in 1 CARTON (14335-172-01) > 40 mL in 1 VIAL, SINGLE-DOSE | 2021-06-01 | 0000-00-00 | No | No | Current |